Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...

To mark the NHS’ 75 th anniversary this year, NHS England partnered with the London College of Communication (LCC), part of the University of the Arts London, to provide students with real-life ...

The 2025 EHA Congress Awards honoured outstanding contributions across clinical care, research, education, and advocacy in ...

SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the appointment of Jay Backstrom ...

The mission aims to eliminate sickle cell anaemia by 2047 through universal screening and targeted tribal interventions.

Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.

Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

In May, Google released MedGemma, which uses both the MedQA and Afri-MedQA datasets to form a more globally accessible healthcare chatbot. MedGemma has several versions, including 4-billion and ...

The firm sees the astonishingly high cost of "cellular, gene and RNA therapies" — high-tech treatments for conditions like ...

In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV1 and superior in reducing sweat chloride compared to ...

Acute chest syndrome associated with sickle cell is driven by the abnormal activation of the complement cascade, per a study.